This article is more than 5 years old. Information may no longer be current.
CDC publishes ACIP recommendations for HPV vaccination in males
CDC. MMWR. 2011;60(50):1705-1708.
Click Here to Manage Email Alerts
The CDC recently published the Advisory Committee on Immunization Practices recommendations on the routine use of human papillomavirus vaccine.
In October, ACIP recommended routine use of quadrivalent HPV vaccine (HPV4; Gardasil, Merck) in males aged 11 or 12 years. ACIP also recommended vaccination with HPV4 for males aged 13 to 21 years who have not been vaccinated previously or who have not completed the three-dose series; males aged 22 to 26 years also may be vaccinated.
These recommendations replace the October 2009 ACIP guidance that HPV4 may be given to males aged 9 to 26 years.
For special populations, including patients who are immunocompromised and for men who have sex with men, ACIP recommends routine vaccination with HPV4 for all males, including those who are immunocompromised, and vaccination through age 26 years for those who have not been vaccinated previously or who have not completed the three-dose series.
Additional information on ACIP recommendations is available at www.cdc.gov/vaccines/recs/acip/#recs.
 |
Follow the PediatricSuperSite.com on Twitter. |